This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Rising Costs Hurt HCA Healthcare's (HCA) Q3 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results are likely to reflect an increased occupancy rate and a lower average length of stay.
Analysts Estimate Universal Health Services (UHS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare (HCA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
(HCA) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $237.42, moving +1.04% from the previous trading session.
Cigna's (CI) Evernorth Acquires Bright.md Technology Platform
by Zacks Equity Research
Cigna's (CI) Evernorth arm acquires Bright.md, enhancing MDLIVE's virtual care capabilities.
Cigna's (CI) Evernorth Launches Value-Based Care Program
by Zacks Equity Research
Cigna's (CI) Evernorth arm introduces a measurement-based care program for its behavioral health network.
3 Sector ETFs & Stocks to Bet on Upbeat September Jobs Data
by Sanghamitra Saha
The U.S. economy added 336,000 jobs in September 2023, well above an upwardly revised 227,000 in August, and beating market forecasts of 170,000.
HCA Healthcare (HCA) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
HCA Healthcare (HCA) closed at $243.36 in the latest trading session, marking a -0.25% move from the prior day.
The Zacks Analyst Blog Highlights Intel, Anheuser-Busch InBev, HCA Healthcare, Moderna and DuPont de Nemours
by Zacks Equity Research
Intel, Anheuser-Busch InBev, HCA Healthcare, Moderna and DuPont de Nemours are included in this Analyst Blog.
Top Stock Reports for Intel, Anheuser-Busch & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Intel Corporation (INTC), Anheuser-Busch InBev SA/NV (BUD) and HCA Healthcare, Inc. (HCA).
Tenet Healthcare (THC) Rides on Strong Patient Volumes, Buyouts
by Zacks Equity Research
Tenet Healthcare (THC) gains from expanding patient admissions, diversified treatment network, acquisitions and robust cash-generating abilities.
HCA Healthcare (HCA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $247.26 in the latest trading session, marking a -0.48% move from the prior day.
Here's Why Investors Should Retain Acadia Healthcare (ACHC)
by Zacks Equity Research
Acadia Healthcare (ACHC) is well-poised for growth on the solid demand for behavioral healthcare services, the continuous pursuit of expansion initiatives and growing cash reserves.
HCA Healthcare (HCA) Stock Moves -0.3%: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $253.44 in the latest trading session, marking a -0.3% move from the prior day.
HCA (HCA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Fed Dampens Wall Street Sentiments: 5 Safe Stock Picks
by Nalak Das
We have narrowed our search to five stocks from defensive sectors. These are: PEP, PG, AWK, VST, HCA.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems are part of the Zacks Industry Outlook article.
Tenet Healthcare (THC) & Oracle Unite to Improve Efficiency
by Zacks Equity Research
Tenet Healthcare (THC) collaborates with Oracle Cloud HCM to improve and automate human resources and payroll processes.
5 Hospital Stocks to Watch Amid Improving Industry Trends
by Kaibalya Pravo Dey
Cost optimization efforts and rising patient volumes for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving occupancy rates.
Here's Why Investors Should Retain Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva
by Zacks Equity Research
Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $263.58, moving +0.42% from the previous trading session.
Top Stock Reports for Visa, Chubb & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).
Here's Why Investors are Buying HCA Healthcare (HCA) Stock Now
by Zacks Equity Research
With seniors resuming delayed elective procedures, demand for services provided by HCA Healthcare (HCA) is likely to rise.